Portopulmonary hypertension -: Survival and prognostic factors

被引:167
|
作者
Le Pavec, Jerome [1 ]
Souza, Rogerio [1 ]
Herve, Philippe [1 ]
Lebrec, Didier [2 ,3 ]
Savale, Laurent [1 ]
Tcherakian, Colas [1 ]
Jais, Xavier [1 ]
Yaici, Azzedine [1 ]
Humbert, Marc [1 ]
Simonneau, Gerald [1 ]
Sitbon, Olivier [1 ]
机构
[1] Univ Paris 11, Hop Antoine Beclere, AP HP, Serv Pneumol & Reanimat,UPRES 2705, Clamart, France
[2] Hop Beaujon, INSERM, U773, Ctr Rech Biomed Bichat Beaujon,CRB3,AP HP, Clichy, France
[3] Hop Beaujon, AP HP, Serv Hepatol, Clichy, France
关键词
pulmonary hypertension; portal hypertension; portopulmonary hypertension; cirrhosis; survival;
D O I
10.1164/rccm.200804-613OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Portopulmonary hypertension (PoPH) can be defined as elevation of pulmonary arterial pressure and pulmonary vascular resistance in the setting of portal hypertension. Survival results in PoPH are contrasting, and prognostic factors need to be identified. Objectives: To analyze long-term survival in a large cohort of patients with PoPH with the aim of determining the independent variables affecting survival. Methods: We retrospectively analyzed charts of all patients referred to the French Referral Center for pulmonary arterial hypertension with the diagnosis of PoPH between 1984 and 2004. Measurements and Main Results: The study population comprised 154 patients; 57% male. Mean age at diagnosis was 49 +/- 11 years, 60%of patients were in New York Heart Association functional class III-IV, and mean 6-minute walk distance was 326 +/- 116 m. Hemodynamic measurements showed a mean pulmonary arterial pressure of 53 +/- 13 mm Hg, cardiac index of 2.9 0.9 L/min/m(2), and pulmonary vascular resistance of 752 +/- 377 dyn/s/cm(5). Portal hypertension was related to cirrhosis in 136 patients, with a severity assessed as follows: Child-Pugh class A 51%, Child-Pugh class B 38%, Child-Pugh class C 11%. Overall survival rates at 1, 3, and 5 yr were 88, 75, and 68%, respectively. Multivariate regression analysis individualized the presence and severity of cirrhosis and cardiac index as major independent prognostic factors. Conclusions: Prognosis in PoPH is mainly related to the presence and severity of cirrhosis and to cardiac function. The place of pulmonary arterial hypertension-specific therapies remains to be determined in the setting of PoPH.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 50 条
  • [1] Portopulmonary hypertension and the issue of survival
    Krowka, MJ
    LIVER TRANSPLANTATION, 2005, 11 (09) : 1026 - 1027
  • [2] Factors associated with portopulmonary hypertension
    Akahane, Takemi
    HEPATOLOGY RESEARCH, 2021, 51 (12) : 1179 - 1180
  • [3] Hemodynamics and survival of patients with portopulmonary hypertension
    Kawut, SM
    Taichman, DB
    Ahya, VN
    Kaplan, S
    Archer-Chicko, CL
    Kimmel, SE
    Palevsky, HI
    LIVER TRANSPLANTATION, 2005, 11 (09) : 1107 - 1111
  • [4] Clinical risk factors for portopulmonary hypertension
    Kawut, Steven M.
    Krowka, Michaelj.
    Trotter, James F.
    Roberts, Kari E.
    Benza, Raymond L.
    Badesch, David B.
    Taichman, Darren B.
    Horn, Evelyn M.
    Zacks, Steven
    Kaplowitz, Neil
    Brown, Robert S., Jr.
    Fallon, Michael B.
    HEPATOLOGY, 2008, 48 (01) : 196 - 203
  • [5] Pulmonary hypertension: survival and prognostic factors by subgroups
    Soriente, Lucia
    Visco, Valeria
    Aliberti, Chiara
    Ciccarelli, Michele
    Galasso, Gennaro
    Ardovino, Pasquale
    Vigorito, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [6] Pulmonary hypertension: survival and prognostic factors by subgroups
    Soriente, Lucia
    Visco, Valeria
    Aliberti, Chiara
    Ciccarelli, Michele
    Galasso, Gennaro
    Ardovino, Pasquale
    Vigorito, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [7] The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
    Yukiko Takahashi
    Keiko Yamamoto
    Seiichiro Sakao
    Takao Takeuchi
    Rika Suda
    Nobuhiro Tanabe
    Koichiro Tatsumi
    BMC Pulmonary Medicine, 21
  • [8] Survival in portopulmonary hypertension and orthotopic liver transplantation.
    Swanson, K
    Burger, C
    Rosen, C
    Steers, J
    Wiesner, R
    Krowka, M
    LIVER TRANSPLANTATION, 2005, 11 (07) : C71 - C71
  • [9] The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
    Takahashi, Yukiko
    Yamamoto, Keiko
    Sakao, Seiichiro
    Takeuchi, Takao
    Suda, Rika
    Tanabe, Nobuhiro
    Tatsumi, Koichiro
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [10] PROGNOSTIC FACTORS FOR SURVIVAL IN IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
    Popplewell, C. R.
    Greenhalgh, A.
    Corris, P. A.
    THORAX, 2017, 72 : A176 - A176